REQUEST A DEMO
Total
USD $0.00
Search more companies

Novartis Biociencias S.A. (Brazil)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Novartis Biociencias S.A. Profile Updated: February 06, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Portuguese Download a sample report

Novartis Biociencias S.A. is a company located in Sao Paulo, Brazil. It was created in 1996 through the merger of Ciba-Geigy and Sandoz. The company has a rich history in the development of innovative products, with its predecessor companies specializing in the production of chemicals and pharmaceuticals. Novartis focuses on innovation to meet the unmet needs of patients worldwide. Their main products include a global portfolio of over 50 patented innovative medicines, many of which are leading products in their therapeutic areas and fall under the category of immunobiological drugs. These drugs are considered one of the greatest advancements in history and have significantly improved global health. Novartis also offers biosimilar and generic medicines, with their division Sandoz being a global leader in the industry. Sandoz provides over 1,000 different types of high-quality and affordable medicines in various therapeutic areas. Novartis also collaborates with strategic commercial partners to address complex challenges in healthcare ecosystems. They are committed to informing and updating patients about any discontinuation of their products as per regulatory requirements. For more information and clarification about their products, customers can contact their Customer Information Service.

Headquarters
Avenida Professor Vicente Rao 90 90, Jardim Petropolis
Sao Paulo; Sao Paulo; Postal Code: 04636900

Contact Details: Purchase the Novartis Biociencias S.A. report to view the information.

Website: http://www.novartis.com.br

Basic Information
Total Employees:
Purchase the Novartis Biociencias S.A. report to view the information.
Outstanding Shares:
Purchase the Novartis Biociencias S.A. report to view the information.
Registered Capital:
Purchase the Novartis Biociencias S.A. report to view the information.
Financial Auditors:
Purchase the Novartis Biociencias S.A. report to view the information.
Incorporation Date:
July 27, 1966
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Novartis Biociencias S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BRL. Absolute financial data is included in the purchased report.
Net sales revenue
17.54%
Total operating revenue
17.54%
Operating profit (EBIT)
157.27%
EBITDA
149.47%
Net Profit (Loss) for the Period
135.63%
Total assets
-9.12%
Total equity
37.43%
Operating Profit Margin (ROS)
11.02%
Net Profit Margin
6.88%
Return on Equity (ROE)
35.98%
Debt to Equity Ratio
-109.25%
Quick Ratio
0.2%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?